Rolling Meadows, IL (PRWEB) July 22, 2013
Consumers are satisfied with wrinkle-relaxing injections 92 percent of the time, a procedure they seek more often from dermatologic surgeons than other providers, according to survey data released by the American Society for Dermatologic Surgery.
The first-ever ASDS Consumer Survey on Cosmetic Dermatologic Procedures asked more than 6,300 consumers for their opinions on cosmetic treatments in general and ratings for 10 specific procedures – from ultrasound/light treatments and body sculpting to laser hair removal.
Wrinkle-relaxing injections tied with soft-tissue treatments for the highest overall satisfaction rating (92 percent) of the 10 treatment categories. Of the consumers who were satisfied with their wrinkle-relaxing injections, 38 percent said they were “extremely satisfied,” while 54 percent said they were “moderately satisfied.”
Wrinkle-relaxing injections can dramatically soften facial expression lines, frown lines and crow’s feet with effects lasting from three to six months. The injections relax and re-educate the muscles, smoothing out wrinkles in a quick procedure with minimal discomfort. Wrinkle-relaxing injections also may be used in combination with other cosmetic procedures – such as soft-tissue fillers and chemical peels – to help reduce or smooth wrinkles.
Three types of botulinum toxin A – also called neuromodulators – are available: Botox (Allergan), Dysport (Medicis) and Xeomin (Merz).
While consumers listed excess weight as their greatest cosmetic concern, more than half also are bothered by conditions treatable with wrinkle-relaxing injections – mid-face folds and wrinkles; lines and wrinkles around the eyes; lines and wrinkles between the eyebrows; and forehead lines and wrinkles.
ASDS members performed nearly 1.5 million wrinkle-relaxing injections in 2012, almost a 25 percent increase from the 1.2 million treatments performed in 2011, according to the 2012 ASDS Survey on Dermatologic Procedures.
“The emergence and efficacy of wrinkle-relaxing injections has made them a very popular procedure for consumers,” said ASDS President Timothy C. Flynn, M.D. “Treatment breakthroughs – many spearheaded by ASDS members – have made these procedures popular and effective.”
Nearly 60 percent of survey respondents said they were considering wrinkle-relaxing injections in the future. When asked why they had not yet had a treatment, respondents listed cost (80 percent), concerns over not getting the desired results (36 percent) and recovery time (33 percent) as the most common reasons.
The 9 percent of survey respondents who have undergone wrinkle-relaxing injections indicated that dermatologists were their physicians of choice and, of those, more than two out of three say their treatment was performed by a dermatologic surgeon.
“ASDS members are the obvious choice for patients for both cosmetic and medically necessary procedures because we are the skin experts,” Dr. Flynn said. “Not only are these procedures more affordable and available today than they have ever been before, but many require very little – if any – recovery time.”
Consumers undergoing more than one cosmetic procedure listed wrinkle-relaxing injections (26 percent) as the procedure that gave them the best results, followed by soft-tissue fillers (21 percent).
About the ASDS
The American Society for Dermatologic Surgery (ASDS) is the largest specialty organization exclusively representing dermatologic surgeons who have unique training and experience to treat the health, function and beauty of the skin. ASDS members are pioneers in the field. Many are involved in the clinical studies that bring popular treatments to revitalize skin and fill and diminish wrinkles to the forefront. Their work has helped create and enhance many of the devices that remove blemishes, hair and fat, and tighten skin. ASDS members also are experts in skin cancer prevention, detection and treatment. As the incidence of skin cancer rises, ASDS members are committed to taking steps to minimize the life-threatening effects of this disease. For more information, visit asds.net.
Read the full story at http://www.prweb.com/releases/2013/7/prweb10946522.htm.
Copyright©2012 Vocus, Inc.
All rights reserved